Related Experiment Video
Updated: Oct 20, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator
K C Chou1, K D Watenpaugh, R L Heinrikson
1Computer-Aided Drug Discovery, Pharmacia & Upjohn, Kalamazoo, Michigan 49007-4940, USA.
Abstract:
Tau protein kinase II (TPKII) is a heterodimer comprising a catalytic cyclin-dependent kinase subunit (Cdk5) and a regulatory protein called neuronal Cdk5 activator (Nck5a). TPKII is somewhat reminiscent, therefore, of the Cdk2-cyclin complex important in cell cycle regulation. In fact, although the amino acid sequence of Nck5a has little similarity to those of cyclins, recent experimental results obtained by site-directed mutagenesis studies have indicated that its activation domain, Nck5a*, may adopt a conformation of the cyclin-fold structure. Based on this structural inference, a 3-dimensional model of the Cdk5-Nck5a*-ATP complex was derived from the X-ray structure of Cdk2-cyclinA-ATP complex. The computed structure for TPKII is fully compatible with experimental data derived from studies of the Cdk5-Nck5a system, and also predicts which amino acid residues might be involved in formation of the Cdk5-Nck5a* interface and ATP binding pocket in TPKII. The computational structure also shows the interactive region of Nck5a* and the T-loop of Cdk5, a critical region in TPKII which functions as a gate-control-lever of the catalytic cleft. Furthermore, a physical mechanism is put forth to explain why the activation of TPKII is not dependent upon phosphorylation of the Cdk5 subunit, a puzzle long-standing in this area. These findings provide a model with which to consider design of compounds which might serve as inhibitors of TPKII.
Insights
A 3D model of Tau protein kinase II (TPKII) reveals its structure and activation mechanism. This computational model, based on experimental data, aids in designing potential TPKII inhibitors.
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Biology
Background:
- Tau protein kinase II (TPKII) is a crucial enzyme composed of Cdk5 and Nck5a.
- Its activation mechanism has been a long-standing puzzle, particularly regarding Cdk5 phosphorylation.
- Nck5a's activation domain may adopt a cyclin-fold structure, similar to Cdk2-cyclin complexes.
Purpose of the Study:
- To derive a 3D structural model of the Cdk5-Nck5a*-ATP complex.
- To elucidate the structural basis of TPKII activation and identify key interacting residues.
- To propose a mechanism for TPKII activation independent of Cdk5 phosphorylation.
Main Methods:
- Computational modeling based on the X-ray structure of Cdk2-cyclinA-ATP.
- Site-directed mutagenesis data integration.
- Analysis of protein-protein interfaces and ATP binding pockets.
Main Results:
- A 3D model of the Cdk5-Nck5a*-ATP complex compatible with experimental data was generated.
- Key residues at the Cdk5-Nck5a* interface and ATP binding site were predicted.
- The model highlights the interaction between Nck5a* and Cdk5's T-loop, crucial for catalytic activity.
Conclusions:
- The study provides a structural framework for understanding TPKII function.
- A mechanism explaining TPKII activation independent of Cdk5 phosphorylation is proposed.
- The findings offer a basis for designing novel TPKII inhibitors.
More Related Videos
13:15Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
Published on: February 25, 2016
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
Positive Regulator Molecules
Anaphase Promoting Complex
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...